Life Sciences Health

Bridging Global Communications in 200+ languages
What Does Stress Do To Our Body?

This article is part 1 of a mini-series focusing on how the body reacts to stressors. This installment looks at the physiological reaction to stress and how this can impact a person’s overall health. Have you ever thought about what stress could do to your body? You...

Who We Are

CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission.

How We Serve You

We are dedicated to industry-standard knowledge and quality.

Our translation solutions are intended for document types relating to every stage of product development life cycle. CSOFT works extensively with medical professionals who are dedicated to prevalent therapeutic areas such as:

  • Cardiology
  • Dental
  • Dermatology
  • Gastroenterology
  • Infections
  • Neurology
  • Oncology
  • Orthopedics
  • Genetic Disease
  • Hematology
  • Hepatology
  • Immunology
  • Pediatrics
  • Psychology
  • Rare Diseases
  • Women’s Health

Asia Regulatory Services

CSOFT’s expert consultants provide our clients with insight into China’s pharmaceutical industry and to help strategize regulatory and commercialization plans. We strive to ease complex issues our clients are facing such as obtaining the NMPA’s approval to register and incorporate new medical products in China’s market.
CSOFT provides consulting to our clients so they can gain a better understanding of how to approach this dynamic yet challenging market

Regulatory Digest

CSOFT life science blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.

China Creating a Framework on Real-World Evidence

Purpose of Real-World Evidence/Real-World Data To test new treatments, pharmaceutical companies adopt a method called "Randomized Controlled Trial" (RCT). There are two design groups within a trial. Participants from the "Randomized" group are chosen...